Quality and future of clinical laboratories: The Vico's whole cyclical theory of the recurring cycles

Clinical Chemistry and Laboratory Medicine

Volumn 56, Issue 6, 2018, Pages 901-908

  Plebani, Mario ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

brain to brain loop; clinical laboratory; commodity; drivers for change; hospital based model; quality

Indexed keywords

AUTOMATION; CLINICAL DECISION MAKING; CLINICAL LABORATORY; CLINICAL OUTCOME; COST; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEALTH CARE; HEALTH CARE DELIVERY; HUMAN; LABORATORY TEST; MEDICAL HISTORY; PATHOLOGIST; PATIENT SAFETY; PRIORITY JOURNAL; RELIABILITY; REVIEW; TOTAL QUALITY MANAGEMENT; TURNAROUND TIME; UNITED STATES; CLINICAL LABORATORY SERVICE; ECONOMICS; FORECASTING; HEALTH CARE QUALITY; STANDARDS; THEORETICAL MODEL; TRENDS;

CLINICAL LABORATORY SERVICES; FORECASTING; HUMANS; MODELS, THEORETICAL; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 85042017677     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2018-0009     Document Type: Review

References (52)

1. Plebani M. Clinical laboratories: Production industry or medical services Clin Chem Lab Med 2015;53:995-1004.
2. Wright JR Jr. The politics underlying the provision of and changes in pathology and laboratory services in the United States during the roaring twenties. Arch Pathol Lab Med 2016;140:983-91.
3. Strom CM. Changing trend in laboratory testing in the United States. Clin Lab Med 2012;32:651-64.
4. Plebani M. Quality in laboratory medicine: 50 years on. Clin Biochem 2017;50:101-4.
5. Adeli K. Laboratory medicine- A hidden treasure in healthcare. Clin Biochem 2017;50:645-7.
6. Plebani M, EFLM task force on performance specifications for the extra-analytical phases. Performance specifications for the extra-analytical phases of laboratory testing: Why and how. Clin Biochem 2017;50:550-4.
7. Porter ME. A strategy for health care reform-toward a valuebased system. N Engl J Med 2009;361:109-12.
8. Plebani M. The changing face of clinical laboratories. Clin Chem Lab Med 1999;37:711-7.
9. Conn RB. Clinical laboratories: Profit center, production industry or patient-care resource N Engl J Med 1978;298:422-7.
10. Price CP, John AS, Christenson R, Scharnhorst V, Oellerich M, Jones P, et al. Leveraging the real value of laboratory medicine with the value proposition. Clin Chim Acta 2016;462:183-6.
11. Plebani M, Lippi G. Is laboratory medicine a dying profession Blessed are those who have not seen and yet have believed. Clin Biochem 2010;43:939-41.
12. Wright JR Jr. The American College of Surgeons, minimum standards for hospitals, the provision of high-quality laboratory services. Arch Pathol Lab Med 2017;141:704-17.
13. Davis L. Fellowship of surgeons: A history of the American College of Surgeons. Chicago, IL: American College of Surgeons, 1960.
14. Hospital Information and Service Department, American College of Surgeons. A manual of hospital standardization. https://archive.org/details/Hospital Standardization Manual 1926. Published 1926. Accessed 15 Oct 2017.
15. Vico G. The new science. New York: Cornell University Press Ithaca, 1948.
16. Jones BA, Bekeris LG, Nakhleh RE, Walsh MK, Valenstein PN, College of American Pathologists. Physician satisfaction with clinical laboratory services: A College of American Pathologists Q-probes study of 138 institutions. Arch Pathol Lab Med 2009;133:38-43.
17. McCall SJ, Souers RJ, Blond B, Massie L. Physician satisfaction with clinical laboratory services: A College of American Pathologists Q-Probes Study of 81 Institutions. Arch Pathol Lab Med 2016;140:1098-103.
18. Seaberg RS, Stallone RO, Statland BE. The role of total laboratory automation in a consolidated laboratory network. Clin Chem 2000;46:751-6.
19. Plebani M, Panteghini M. Promoting clinical and laboratory interaction by harmonization. Clin Chim Acta 2014;432:15-21.
20. Institute of Medicine. Improving diagnosis in health care. Washington, DC: National Academies of Sciences, Engineering, Medicine, 2015. Available at http://iom. nationalacademies.org/Reports/2015/Improving-Diagnosisin-Healthcare.aspx.
21. Dickerson JA, Fletcher AH, Procop G, Keren D, Singh IR, Garcia JJ, et al. Transforming laboratory utilization review into laboratory stewardship: Guidelines by the PLUGS National Committee for Laboratory Stewardship. J Appl Lab Med 2017;2: 259-68.
22. Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardshipleveraging the laboratory to improve antimicrobial use. J Am Med Assoc 2017; 318:607-8.
23. Messacar K, Parker SK, Todd JK, Dominguez SR. Implementation of rapid molecular infectious disease diagnostics: The role of diagnostic and antimicrobial stewardship. J Clin Microbiol 2017;55:715-23.
24. Pelloso M, Basso D, Padoan A, Fogar P, Plebani M. Computerbased-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting. J Clin Pathol 2016;69:777-83.
25. Eaton KP, Levy K, Soong C, Pahwa AK, Petrilli C, Ziemba JB. Evidence-based guidelines to eliminate repetitive laboratory testing. JAMA Intern Med 2017;177:1833-9.
26. Piva E, Pelloso M, Penello L, Plebani M. Laboratory critical values: Automated notification supports effective clinical decision making. Clin Biochem 2014;47:1163-8.
27. Piva E, Sciacovelli L, Pelloso M, Plebani M. Performance specifications of critical results management. Clin Biochem 2017;50:617-21.
28. Bartlett RC. Medical microbiology: Quality costs and clinical relevance. New York, NY: Wiley, 1974.
29. Dooris M. Expert voices for change: Bridging the silos-towards healthy and sustainable settings for the 21st century. Health Place 2013;20:39-50.
30. Porter ME. What is value in health care N Engl J Med 2010;363:2477-81.
31. Tahara DC, Green RP. Strategic re-design of team-based patient-focused health care services. Adv Health Care Manag 2014;16:3-22.
32. Rockwell KL. Direct-to-consumer medical testing in the era of value-based care. J Am Med Assoc 2017;317:2485-6.
33. Lovett KM, Mackey TK, Liang BA. Evaluating the evidence: Directto-consumer screening tests advertised online. J Med Screen 2012;19:141-53.
34. McGuire AL, Burke W. Health system implications of direct-toconsumer personal genome testing. Public Health Genomics 2011;14:53-8.
35. Cosby K. Medical decision making. In: Croskerry P, Cosby K, Graber M, Singh H, editors. Diagnosis: Interpreting the shadows. Boca Raton, FL: CRC Press Taylo & Francis Group, 2017.
36. Plebani M, Laposata M, Lundberg GD. The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Pathol 2011;136:829-33.
37. Srinivasan D, Desai NR. The impact of the transition from value to value on heart failure care: Implications of novel payment models and quality improvement initiatives. J Cardiac Fail 2017;23:615-20.
38. Bindman AB, Pronovost PJ, Asch DA. Funding innovation ina learning health care system. JAMA 2018;19:119-20.
39. Herzlinger RE, Schleicher SM, Mullangi S. Health care delivery innovations that integrate care Yes!: But integrating what J Am Med Assoc 2016;315:1109-10.
40. Hadker N, Garg S, Costanzo C, van der Helm W, Creeden J. Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test Learnings from a modeling analysis from a German payer perspective. Hypertens Pregnancy 2013;32:105-19.
41. Di Martino D, Cetin I, Frusca T, Ferrazzi E, Fuse' F, Gervasi MT, et al. Italian advisory board: SFlt-1/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management. Eur J Obstet Gynecol Reprod Biol 2016;206:70-3.
42. Lee J, Tollefson E, Daly M, Kielb E. A generalized health economic and outcomes research model for the evaluation of companion diagnostics and targeted therapies. Expert Rev Pharmacoecon Outcomes Res 2013;13:361-70.
43. The Centre for International Economics. The economic value of pathology: Achieving better health, better use of health resources. www.TheCIE.com.au. Accessed on 21 Dec 2017.
44. Segal L, Dalton AC, Richardson J. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promot Int 1998;13:197-209.
45. Plebani M. Analytical quality: An unfinished journey. Clin Chem Lab Med 2018;56:357-359.
46. Vogeser M, Seger C. Irregular analytical errors in diagnostic testing- A novel concept. Clin Chem Lab Med 2018;56:386-96.
47. Clerico A, Belloni L, Carrozza C, Correale M, Dittadi R, Dotti C, et al. A Black Swan in clinical laboratory practice: The analytical error due to interferences in immunoassay methods. Clin Chem Lab Med 2018;56:397-402.
48. Price CP, Wolstenholme J, McGinley P, St John A. Translational health economics: The key to accountable adoption of in vitro diagnostic technologies. Health Serv Manage Res 2017:951484817736727. doi:10.1177/0951484817736727. [Epub ahead of print].
49. Misialek MJ. Valuing value: The changing role of pathologists. Am J Clin Pathol 2014;142:584-5.
50. Plebani M. Towards a new paradigm in laboratory medicine: The five rights. Clin Chem Lab Med 2016;54:1881-91.
51. Plebani M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Biochem Rev 2012;33:85-8.
52. Lippi G, Plebani M. The add value of laboratory diagnostics: The many reasons why decision-makers should actually care. J Lab Precis Med 2017;2:100.